<DOC>
	<DOCNO>NCT00812630</DOCNO>
	<brief_summary>This two-part trial assess effect MENT blood pressure . The first part trial open-label pilot study verify MENT gel formulation delivers appropriate drug level . Upon confirm MENT serum level within require range , clinical trial material produce label . Consequently , second part trial , main study , proceed approximately two month conclusion pilot study . The main study , randomize , double-blind , placebo-controlled study .</brief_summary>
	<brief_title>A Two-part Trial Assessing Effects 7Î±-methyl-19-nortestosterone ( MENT ) Blood Pressure Normal Men : Open-label Pilot Study Followed Randomized , Double-blind , Placebo-controlled Study</brief_title>
	<detailed_description />
	<mesh_term>Nandrolone</mesh_term>
	<mesh_term>Nandrolone decanoate</mesh_term>
	<mesh_term>Nandrolone phenpropionate</mesh_term>
	<criteria>Healthy men age 1840 Man sperm concentration great equal 15 x 106/mL screen Man use hormonal therapy last six month Man testosterone level 2701070 ng/dL screen Man hypertensive , define diastolic BP great equal 85 mmHg systolic BP great equal 140 mmHg ( average 2nd 3rd 3 measurement 10 minute rest ) screen baseline ABPM average diastolic great equal 85 mmHg systolic great equal 130 mmHg take hypertensive medication Man BMI 33 kg/m2 Man active history cerebrovascular cardiovascular disease Man chronic acute liver renal disease Man history significant psychiatric disorder , include severe depression Man dermatitis , psoriasis severe skin disorder Man clinically significant abnormality laboratory safety test</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>male hormonal contraception</keyword>
	<keyword>Blood pressure , sperm concentration</keyword>
</DOC>